SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 356 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $8,000 | -99.0% | 45 | -99.3% | 0.00% | -99.1% |
Q2 2014 | $778,000 | +3.2% | 6,305 | -13.5% | 0.22% | -8.8% |
Q1 2014 | $754,000 | -25.6% | 7,285 | -35.3% | 0.24% | -32.5% |
Q4 2013 | $1,013,000 | +36.2% | 11,260 | +1.2% | 0.35% | +18.8% |
Q3 2013 | $744,000 | -0.8% | 11,125 | -1.9% | 0.30% | -11.3% |
Q2 2013 | $750,000 | – | 11,345 | – | 0.34% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 300,000 | $46,872,000 | 24.29% |
HealthCor Management, L.P. | 935,100 | $146,100,000 | 7.50% |
1492 Capital Management LLC | 70,167 | $10,963,000 | 6.07% |
Visium Asset Management, LP | 2,301,629 | $359,607,000 | 5.31% |
HWG Holdings LP | 39,621 | $6,190,000 | 4.97% |
Riggs Asset Managment Co. Inc. | 45,649 | $7,132,000 | 4.14% |
Cardinal Capital Management | 49,139 | $7,677,000 | 3.65% |
AMI ASSET MANAGEMENT CORP | 213,398 | $33,341,000 | 3.27% |
BENNETT LAWRENCE MANAGEMENT L L C/NY | 88,435 | $13,817,000 | 3.14% |
Adamant Biomedical Investments AG | 78,210 | $12,220,000 | 3.05% |